ADRIENNE ALEXANDER: Open Payments
NPI 1528617073 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 22 payments from 10 companies in 2025. Trend: 2023 $75 · 2024 $606 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $99 |
| Novo Nordisk Inc | 5 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Lilly USA, LLC | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Ozempic, XIFAXAN, QULIPTA, UBRELVY, ZORYVE, MOUNJARO, Kerendia, FREESTYLE LIBRE.
Industry payments across LA — which companies pay providers there.
